Richard A. J. Janssen

1.7k total citations
27 papers, 1.2k citations indexed

About

Richard A. J. Janssen is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Richard A. J. Janssen has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Richard A. J. Janssen's work include Immunotherapy and Immune Responses (8 papers), RNA Interference and Gene Delivery (4 papers) and Neonatal Respiratory Health Research (3 papers). Richard A. J. Janssen is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), RNA Interference and Gene Delivery (4 papers) and Neonatal Respiratory Health Research (3 papers). Richard A. J. Janssen collaborates with scholars based in Netherlands, United States and Germany. Richard A. J. Janssen's co-authors include James W. Mier, Jan Stallen, Kai S. Erdmann, Claudia Beaurivage, Annemarie Lekkerkerker, Dorothy E. Croall, Jennifer S. Tirnauer, David A. Potter, Masatoshi Maki and Ira M. Herman and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and The Journal of Immunology.

In The Last Decade

Richard A. J. Janssen

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard A. J. Janssen Netherlands 18 570 246 232 203 198 27 1.2k
Sonja Vermeren United Kingdom 17 605 1.1× 181 0.7× 155 0.7× 132 0.7× 421 2.1× 28 1.5k
Olivier Preynat‐Seauve Switzerland 20 655 1.1× 172 0.7× 84 0.4× 288 1.4× 335 1.7× 46 1.4k
Yongliang Liu China 15 554 1.0× 89 0.4× 126 0.5× 190 0.9× 184 0.9× 49 1.1k
Yuichiro Miyaoka Japan 14 1.0k 1.8× 232 0.9× 153 0.7× 281 1.4× 98 0.5× 22 1.8k
Junqi Huang China 19 472 0.8× 112 0.5× 221 1.0× 106 0.5× 88 0.4× 50 945
Yannick D. Benoit Canada 26 915 1.6× 107 0.4× 149 0.6× 311 1.5× 142 0.7× 38 1.5k
Michele Ângela Rodrigues Brazil 18 766 1.3× 52 0.2× 257 1.1× 262 1.3× 97 0.5× 55 1.4k
Jane Sun Australia 21 823 1.4× 152 0.6× 71 0.3× 118 0.6× 64 0.3× 35 1.3k

Countries citing papers authored by Richard A. J. Janssen

Since Specialization
Citations

This map shows the geographic impact of Richard A. J. Janssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard A. J. Janssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard A. J. Janssen more than expected).

Fields of papers citing papers by Richard A. J. Janssen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard A. J. Janssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard A. J. Janssen. The network helps show where Richard A. J. Janssen may publish in the future.

Co-authorship network of co-authors of Richard A. J. Janssen

This figure shows the co-authorship network connecting the top 25 collaborators of Richard A. J. Janssen. A scholar is included among the top collaborators of Richard A. J. Janssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard A. J. Janssen. Richard A. J. Janssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corallo, Claudio, Angelique van den Heuvel, Thomas Olivier, et al.. (2022). High-throughput 3D microvessel-on-a-chip model to study defective angiogenesis in systemic sclerosis. Scientific Reports. 12(1). 16930–16930. 22 indexed citations
2.
Ongenaert, Maté, Edo Elstak, Henriëtte L. Lanz, et al.. (2021). A 3D Renal Proximal Tubule on Chip Model Phenocopies Lowe Syndrome and Dent II Disease Tubulopathy. International Journal of Molecular Sciences. 22(10). 5361–5361. 17 indexed citations
3.
Pril, Remko de, et al.. (2021). siRNA-based identification of IBD-related targets in human monocyte-derived dendritic cells. Journal of Immunological Methods. 494. 113058–113058. 1 indexed citations
4.
Beaurivage, Claudia, et al.. (2020). Development of a human primary gut-on-a-chip to model inflammatory processes. Scientific Reports. 10(1). 21475–21475. 120 indexed citations
5.
Beaurivage, Claudia, Elena Naumovska, Edo Elstak, et al.. (2019). Development of a Gut-on-a-Chip Model for High Throughput Disease Modeling and Drug Discovery. International Journal of Molecular Sciences. 20(22). 5661–5661. 138 indexed citations
6.
Sutanto, Erika N., Amelia K. Scaffidi, Luke W. Garratt, et al.. (2018). Assessment of p.Phe508del-CFTR functional restoration in pediatric primary cystic fibrosis airway epithelial cells. PLoS ONE. 13(1). e0191618–e0191618. 2 indexed citations
7.
Amatngalim, Gimano D., Jasmijn A. Schrumpf, Renate M. Verhoosel, et al.. (2017). Antibacterial Defense of Human Airway Epithelial Cells from Chronic Obstructive Pulmonary Disease Patients Induced by Acute Exposure to Nontypeable Haemophilus influenzae: Modulation by Cigarette Smoke. Journal of Innate Immunity. 9(4). 359–374. 44 indexed citations
8.
Tielen, Frans, Edo Elstak, Jan Stallen, et al.. (2017). Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells. PLoS ONE. 12(8). e0182974–e0182974. 35 indexed citations
9.
Schwede, Frank, Daniela Bertinetti, Michael A. Hadders, et al.. (2015). Structure-Guided Design of Selective Epac1 and Epac2 Agonists. PLoS Biology. 13(1). e1002038–e1002038. 66 indexed citations
10.
Ghotra, Veerander P.S., Shuning He, Geertje van der Horst, et al.. (2014). SYK Is a Candidate Kinase Target for the Treatment of Advanced Prostate Cancer. Cancer Research. 75(1). 230–240. 57 indexed citations
11.
Ley, Stephanie, et al.. (2012). RNAi screen in apoptotic cancer cell-stimulated human macrophages reveals co-regulation of IL-6/IL-10 expression. Immunobiology. 218(1). 40–51. 12 indexed citations
12.
Lekkerkerker, Annemarie, et al.. (2012). Cellular Players in Lung Fibrosis. Current Pharmaceutical Design. 18(27). 4093–4102. 58 indexed citations
13.
Maanen, Marjolein A. van, Susanne P. Stoof, Esmerij P. van der Zanden, et al.. (2009). The α7 nicotinic acetylcholine receptor on fibroblast‐like synoviocytes and in synovial tissue from rheumatoid arthritis patients: A possible role for a key neurotransmitter in synovial inflammation. Arthritis & Rheumatism. 60(5). 1272–1281. 66 indexed citations
14.
Triantis, Vassilis, et al.. (2006). Identification and Characterization of DC-SCRIPT, a Novel Dendritic Cell-Expressed Member of the Zinc Finger Family of Transcriptional Regulators. The Journal of Immunology. 176(2). 1081–1089. 32 indexed citations
15.
Eleveld-Trancikova, Dagmar, Vassilis Triantis, Véronique Moulin, et al.. (2004). The dendritic cell-derived protein DC-STAMP is highly conserved and localizes to the endoplasmic reticulum. Journal of Leukocyte Biology. 77(3). 337–343. 30 indexed citations
16.
Janssen, Richard A. J., et al.. (1998). Ras- and Raf-induced Down-modulation of Non-muscle Tropomyosin Are MEK-independent. Journal of Biological Chemistry. 273(48). 32182–32186. 33 indexed citations
17.
Janssen, Richard A. J., et al.. (1994). The immunobiological effects of interleukin-2 in vivo. Cancer Immunology Immunotherapy. 39(4). 207–216. 38 indexed citations
18.
Janssen, Richard A. J., et al.. (1994). Poor induction of interleukin-2 receptor expression on CD8bright+ cells in whole blood cell cultures with CD3 mAb. Implications for immunotherapy with CD3 mAb. Cancer Immunology Immunotherapy. 38(1). 53–60. 6 indexed citations
19.
Janssen, Richard A. J., Jan Buter, Dirk Th. Sleijfer, et al.. (1993). HLA-Dr-expressing CD8bright cells are only temporarily present in the circulation during subcutaneous recombinant interleukin-2 therapy in renal cell carcinoma patients. Cancer Immunology Immunotherapy. 36(3). 198–204. 11 indexed citations
20.
Buter, Jan, Richard A. J. Janssen, Alexander Martens, et al.. (1993). Phase study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancer. European Journal of Cancer. 29(15). 2108–2113. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026